EMD Millipore Expands Provantage Upstream Bioproduction Services - - BioPharm International

ADVERTISEMENT

EMD Millipore Expands Provantage Upstream Bioproduction Services



EMD Millipore, the life science division of Merck KGaA, reported the expansion of its upstream services into North America as part of its Provantage biodevelopment and clinical supply offering. The company's Massachusetts facilities will now offer upstream capabilities including media and feed screening, small-scale material production, and optimization of conditions for scale-up and technology transfer.

This expansion allows EMD Millipore's North American customers to access the same services European customers have received at the company's GMP biodevelopment center in Martillac, France.

Source: EMD Millipore

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines

Click here